Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 6Recruiting 2Active not recruiting 2Withdrawn 1Unknown 1Approved for marketing 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Gastrointestinal Stromal Tumors 2

Interventions

Sunitinib 5ripretinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Biopsy 2regorafenib 1binimetinib 1Temozolomide 1TAS-116 1Sorafenib 1Rogaratinib 1Poly(ADP-ribose) Polymerase Inhibitors 1Nivolumab 1Midazolam 1Ipilimumab 1CTLA-4 Antigen 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Gastrointestinal Stromal Tumors × ripretinib × Clear all
NCT03673501 2026-02-05

INTRIGUE

Deciphera Pharmaceuticals, LLC

Phase 3 Active not recruiting
453 enrolled 20 charts
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05734105 2025-12-17

INSIGHT

Deciphera Pharmaceuticals, LLC

Phase 3 Active not recruiting
54 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡